MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Itokawa, M.
Right arrow Articles by Uhl, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Itokawa, M.
Right arrow Articles by Uhl, G. R.

Vol. 57, Issue 6, 1093-1103, June 2000

Dopamine Transporter Transmembrane Domain Polar Mutants: Delta G and Delta Delta G Values Implicate Regions Important for Transporter Functions

Masanari Itokawa, Zhicheng Lin, Ning-Sheng Cai,1 Cindy Wu, Shigeo Kitayama,2 Jia-Bei Wang,3 and George R. Uhl

Molecular Neurobiology Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland

Polar residues in dopamine transporter (DAT) transmembrane domains (TMs) are likely to act individually and even interactively in recognizing cocaine and dopamine. We initially evaluated the effects of alanine substitution mutants that remove the polar side chains from residues in each of the 12 putative DAT TMs on the recognition of dopamine and the cocaine analog CFT. Eleven combination mutants with multiple substitutions in DAT TMs 4, 5, 7, or 11 were then selected as candidates for more detailed evaluation based on mutation effects on dopamine and cocaine analog affinities. An evaluation of Gibbs free energy changes displayed by single and combined TM mutants (Delta Go and Delta Delta Goint) reveals three categories of potential interactions among mutants: 1) independent, noncooperative interactions (five influenced CFT and two influenced dopamine affinities), 2) synergistic influences (two for CFT and four for dopamine), and 3) complementation of influences on CFT recognition (four mutants) or on dopamine affinity (five). Combined mutations in TMs 4 and 5 yield the largest Delta Delta Goint values for dopamine uptake. TMs 4 and 11 mutants provide the largest Delta Delta Goint for CFT binding. Interactions between residues lying in DAT TMs 4 and 5 support current DAT structural models that suggest the juxtaposition of these two TMs. These data also support contributions of TM 4 and 11 residues to a polar pocket important for cocaine recognition. These candidate interactive DAT polar domains provide larger target sites for compounds that could modulate specific DAT functions than those provided by single mutations alone.


1 Cellular Neurobiology Branch, NIDA, Intramural Research Program, National Institutes of Health, Bethesda, MD 21224.

2 Department of Pharmacology, Hiroshima University/School of Dentistry, Hiroshima 734-8553, Japan.

3 Department of Pharmaceutical Science, University of Maryland, Baltimore, MD 21201.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
L. R. Forrest, S. Tavoulari, Y.-W. Zhang, G. Rudnick, and B. Honig
Identification of a chloride ion binding site in Na+/Cl -dependent transporters
PNAS, July 31, 2007; 104(31): 12761 - 12766.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Vaughan, D. S. Sakrikar, M. L. Parnas, S. Adkins, J. D. Foster, R. A. Duval, J. R. Lever, S. S. Kulkarni, and A. Hauck-Newman
Localization of Cocaine Analog [125I]RTI 82 Irreversible Binding to Transmembrane Domain 6 of the Dopamine Transporter
J. Biol. Chem., March 23, 2007; 282(12): 8915 - 8925.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. J. Loland, C. Granas, J. A. Javitch, and U. Gether
Identification of Intracellular Residues in the Dopamine Transporter Critical for Regulation of Transporter Conformation and Cocaine Binding
J. Biol. Chem., January 30, 2004; 279(5): 3228 - 3238.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Z. Lin and G. R. Uhl
Dopamine Transporter Mutants with Cocaine Resistance and Normal Dopamine Uptake Provide Targets for Cocaine Antagonism
Mol. Pharmacol., April 1, 2002; 61(4): 885 - 891.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Z. Lin, W. Wang, and G. R. Uhl
Dopamine Transporter Tryptophan Mutants Highlight Candidate Dopamine- and Cocaine-Selective Domains
Mol. Pharmacol., April 13, 2001; 58(6): 1581 - 1592.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
E. M. Adkins, E. L. Barker, and R. D. Blakely
Interactions of Tryptamine Derivatives with Serotonin Transporter Species Variants Implicate Transmembrane Domain I in Substrate Recognition
Mol. Pharmacol., March 1, 2001; 59(3): 514 - 523.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. G. F. Rasmussen, F. I. Carroll, M. J. Maresch, A. D. Jensen, C. G. Tate, and U. Gether
Biophysical Characterization of the Cocaine Binding Pocket in the Serotonin Transporter Using a Fluorescent Cocaine Analogue as a Molecular Reporter
J. Biol. Chem., February 9, 2001; 276(7): 4717 - 4723.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Kamdar, K. M. Y. Penado, G. Rudnick, and M. M. Stephan
Functional Role of Critical Stripe Residues in Transmembrane Span 7 of the Serotonin Transporter. EFFECTS OF Na+, Li+, AND METHANETHIOSULFONATE REAGENTS
J. Biol. Chem., February 2, 2001; 276(6): 4038 - 4045.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. E. A. Reith, J. L. Berfield, L. C. Wang, J. V. Ferrer, and J. A. Javitch
The Uptake Inhibitors Cocaine and Benztropine Differentially Alter the Conformation of the Human Dopamine Transporter
J. Biol. Chem., July 27, 2001; 276(31): 29012 - 29018.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics